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Abstract
Background: Acute pyelonephritis (APN) is differently defined according to imaging or clinical criteria. In adults
information on the relationship between imaging and clinical data is lacking.
Our study was aimed at analysing the relationship between the clinical and imaging presentation of APN, defined
according to imaging criteria (parenchymal involvement at MR or CT scan).
Methods: All consecutive patients hospitalized for “non-complicated” APN were considered (June 2005-December
2009). Clinical, biochemical and imaging data at hospitalization were analyzed by univariate and logistic regression
analysis.
Results: There were 119 patients, all females, median age 32 years (15-72). At hospitalization, inflammatory markers
were elevated (CRP median: 12.1 mg/dL, normal < 0.8). Incomplete presentations were frequent: fever was absent
in 6.7%, pain in 17.8%, lower urinary tract symptoms in 52.9%. At CT or MR scan the lesions were bilateral in 12.6%,
multiple in 79.8%; abscesses were present in 39.5%. Renal scars were found in 15.1%. Positive cultures were
correlated with multiple foci (multivariate OR 4.2; CI 1.139-15.515). No other sign/symptom discriminated between
small lesions, abscesses or multifocal involvement.
Conclusions: APN is a protean disease. In the absence of strict correlation with clinical or biochemical markers,
imaging studies are required to assess the severity of kidney involvement.
Keywords: Acute pyelonephritis, upper urinary tract infections, computed tomography, nuclear
magnetic resonance, kidney scars, epidemiology
Background
Acute pyelonephritis (APN) is an extensively described,
well-known disease. The first descriptions date to
ancient Egypt, underlining its severity and its potential
to lead to sepsis, kidney abscesses and destruction of the
kidney parenchyma [1]. In spite of this long history, the
nomenclature of acute pyelonephritis is still controver-
sial and the semantic ambiguities can still cause
confusion.
A general consensus is reached only for the definition
of complicated versus non-complicated pyelonephritis:
the former term refers to the presence of systemic (such
as HIV positivity, diabetes, neoplasia or collagen disease)
or anatomical (such as active stone disease, obstruction,
reflux nephropathy) predisposing factors, the latter term
to their absence [1-4].
As Talner and co-workers underlined over 15 years
ago, there is no agreement on the terminology of acute
pyelonephritis and, as a consequence, on diagnostic defi-
nitions [5]. Indeed there are two distinct and legitimate
definitions, involving different diagnostic approaches.
According to the “classical” one, reported in almost all
textbooks of medicine, the definition is pathological,
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renal biopsy involvement (only rarely performed, limited
to kidney transplants) of the renal parenchyma [5,6].
According to this definition, upper urinary tract infec-
tions (UTI) can be classified as pyelonephritis (with evi-
dence of parenchymal involvement) or pyelitis (without
evidence of parenchymal involvement at imaging). Only
the pathological approach, based on imaging techniques,
is apt to identify the presence of kidney scars. This
approach is often followed in children, as the pediatric
literature usually underlines the importance of renal
scars as a potential cause of progressive kidney damage
and hypertension or of pre-eclampsia later in life [6-11].
Nevertheless the issue is controversial and long-term
effects of kidney scars have yet to be fully demonstrated
[12-14].
The second definition is clinical only. Under the pres-
sure of cost constraints, most Authors in the last decade
have preferred (at least in adults) a clinical definition
based on a classic tetrad of high fever, costovertebral
angle tenderness, signs or symptoms of lower urinary
tract infection and positive urinary cultures. This
approach has the advantage of simplicity and lower
costs but is unable to discriminate between the different
forms of upper urinary tract infections (upper UTI)
[6,15-17].
The therapy of upper urinary tract infections is like-
wise controversial, possibly because of the different pre-
valence of severe parenchymal lesions in the different
series. General agreement is reached only on the poten-
tial danger of kidney abscesses, requiring hospitalization
and long-term antibiotic treatment [6,15-17].
In this context, there are at least two good reasons to
reconsider acute pyelonephritis one century after the
pivotal description by Tiemlich and a decade after the
K-DOQI re-definition of chronic kidney disease (CKD)
[1,18].
The first is the re-definition by the K-DOQI guidelines
of CKD as any persistent alteration of the morphology
of the kidneys or of kidney function. Thus kidney scars
define the presence of CKD, suggesting that the thera-
peutic goals should include their avoidance, along with
the prevention of sepsis and renal abscesses [18].
The second reason regards the impressive improve-
ments of imaging in kidney infections, allowing the
identification of small lesions and the distinction
between healing, fibrotic and edematous (presumably
active) infectious foci [19-30]. However, despite the
improvement in diagnostic tools, very few recent studies
have investigated the relationship between clinical and
imaging presentation in adults. Our previous studies
suggested a relationship between the presence of renal
abscesses at diagnosis and the development of kidney
scars. They also indicated, in a cohort of cases referred
to the Emergency Room, that only imaging data could
distinguish between upper urinary tract infections with
and without parenchymal involvement [31-33].
The aim of the present prospective study (June 2005-
December 2009) was to analyze the clinical and imaging
presentation of all patients hospitalized in our setting, in
which diagnosis of APN was made according to imaging
criteria.
Our goal was to test the relationship between the clin-
ical-laboratory data at presentation and the imaging
data. We reasoned that a strong correlation would allow
a simpler, more rapid identification of the cases with the
severest kidney involvement (abscessed and/or multiple
lesions), requiring hospitalization and long-term therapy,
while the lack of correlation would support the wide use
of imaging techniques.
Methods
Study setting and main diagnostic pathway
All consecutive patients hospitalized for acute pyelone-
phritis in the Urology and Nephrology, Internal Medi-
cine and Emergency Medicine wards of the hospital san
Luigi Gonzaga in the period June 2005-December 2009
were included in the study. All patients were referred to
the Nephrology Unit during hospitalization for the plan-
ning of subsequent follow-up and were followed in the
Nephrology Unit at least until clinical and radiological
healing.
Data were gathered prospectively, starting from the
first clinical visit to the Nephrology Unit.
The san Luigi Gonzaga Hospital is a 300-bed univer-
sity hospital (350, including day-hospital beds); the geo-
graphic area covers approximately 100,000 inhabitants.
All patients were hospitalized from the hospital Emer-
gency Room (ER); the ER performed over 41,000 visits
per year in the first period (May 2005-May 2006) and
over 55,000 per year in the last one (January 2009-
December 2009).
Clinical definitions
The diagnosis of APN was made by the ER physicians;
diagnosis was based on the presence of at least one of
the three main symptoms (fever, costovertebral angle
tenderness or pain, recent or present UTI) and at least
one sign of systemic infection (high WBC or C-reactive
protein). The presence of leukocytes or nitrites was an
ancillary criterion supporting the presence of UTI. The
presence of shivers, routinely evaluated in the Emer-
gency Room as part of the patients’ work-up, was not
uniformly recorded and was not considered as sensitive
enough to be added to the selection criteria.
The diagnosis of present or recent UTI was mainly
based on the clinical history and on the clinical symp-
toms; in fact, in our setting, patients usually start an
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cian or self-prescribed) before undergoing urinary tests,
in particular if they are prone to develop UTI. This is
also the reason why, in our opinion, the prevalence of
positive urinary cultures was relatively low.
All patients with a clinical picture suggestive of APN
underwent abdominal ultrasound, whenever possible in
the ER, and were hospitalized. In patients hospitalized
for fever of unknown origin, in which the diagnosis was
made during hospitalization, ultrasound was performed
subsequently.
In the presence of systemic predisposing factors (any
factor affecting the immune response, including dia-
betes, collagen diseases, chemotherapy, HIV positivity,
neuromuscular diseases) and/or of anatomical predis-
posing factors (any factors causing obstruction, includ-
ing active stone disease, prostatic hypertrophy, kidney
malformations, polycystic kidney disease and indwelling
catheters) the APN was considered as “complicated” or
secondary and the patients were not included in the
present analysis. Regarding the diagnostic pathway, in
the presence of anatomical predisposing factors the
most widely employed technique was CT scan, better in
defining the urinary tract and superior in the definition
of stone disease. Patients with complicated pyelonephri-
tis were followed by the urological team and were not
included in the analysis. Patients with systemic predis-
posing factors (such as diabetes or neoplasia) were fol-
l o w e db yo u rg r o u pb u tw e r en o ti n c l u d e di nt h e
analysis, as the predisposing factors could affect both
presentation and follow-up. Pregnant patients were also
excluded. History of kidney stones was recorded, and
APN was considered as non-complicated in the absence
of kidney stones at imaging at diagnosis or of a history
of having passed a kidney stone in the previous month.
The only morphological exception was the presence of
kidney scars presumably due to previous APN episodes,
on the basis of the spatial relationship with the excre-
tory system, at the first imaging.
Consent for publication and for anonymous manage-
ment of data was obtained either at hospitalization or at
first access in the day-hospital. Prof. Alberto Angeli
from the Ethical Committee of the University of san
Luigi Gonzaga assessed the study and confirmed that
ethical approval was not needed since the study deals
with a non-invasive diagnostic tool used according to its
standard indications in a specific subset of patients, for
which previous indications of the literature are available.
Furthermore the study analyz e st h er e s u l t so b t a i n e di n
clinical practice and no test was performed for the sake
of the study. Approval for the indication of each specific
imaging test is a part of the routine controls of the
Magnetic Resonance or Computerized Tomography
experts, who ask for informed consent for each test and,
in each case, control for the coherence of prescription
of the analysis.
Imaging criteria
The diagnosis of pyelonephritis required demonstration
of involvement of the kidney parenchyma. In cases with
clinical suspicion of APN, in which no predisposing
condition was found at ultrasounds, a “second-line” ima-
ging test was performed. Since patients with non-com-
plicated APN are mostly women of childbearing age,
MR was chosen as the preferred imaging technique and
CT scan or scintigraphy was performed only in the case
of contraindications or logistical problems (long wait
before availability of MR scan). As a rule, imaging data
were obtained within 3 days after hospitalization.
In view of the low sensitivity of ultrasounds for the pre-
sence of parenchymal lesions and the high sensitivity for
obstructive lesions, the ultrasound imaging was used to
identify the presence of anatomical predisposing factors.
At the MR scan, the diagnosis of APN requires the
demonstration of the following: in the basal imaging
test, the presence of minor alteration with non-homoge-
neous hypointensity in T1-weighted sequences and
hyperintensity in T2-weighted sequences. After the
injection of contrast medium (Gadolinium), in T1-
weighted sequences, reduction of parenchymal contrast
enhancement in the affected area is observed. Abscessed
areas are defined by a peripheral halo enhancement
after contrast medium.
Diffusion (DWI) sequences were also studied. APN
is characterized by areas of reduction of the diffusivity
of the water molecules (hyperintense in sequences
b = 600); however the finding is less specific [28].
At the CT scan, the diagnosis of APN requires the
demonstration of the following alterations after contrast
medium: decreased enhancement with a “striped” effect
of the renal parenchyma; the triangular shape originally
described (lobar nephronia) in the area of decreased
perfusion is typical, but not required for diagnosis.
Kidney abscesses are defined by the presence of a
hyperintense peripheral border, with a marked hypoden-
sity of the lesion (necrosis), after contrast medium.
Ancillary signs of APN, both at CT and MR scans, are:
kidney swelling, perinephric inflammatory fluid and
stranding of the perinephric fat and occasionally a mini-
mal dilation of the urinary tract [28].
At DMSA-scintigraphy, the diagnosis of APN requires
the demonstration of areas of altered perfusion; the defi-
nition of kidney abscesses is not possible by this
technique.
Data collection and analysis
The following general data were collected: age, sex, par-
ity, country of origin, previous UTI, previous history of
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patients with kidney stones were not included. At refer-
ral, the following clinical data were collected: fever (pre-
sence, considered as > 37°C; maximum level on the day
of hospitalization), costovertebral angle-tenderness,
lower UTI symptoms, other symptoms; antibiotic ther-
apy within the last 72 hours; other therapies.
Laboratory data were obtained by standard laboratory
methods. The following data, obtained in the Emergency
Room at hospitalization, were considered: serum creati-
nine, CRP, blood cell counts, urinary culture (available
in all cases), hemocultures and results of dipstick urina-
lysis were also recorded when available.
On the basis of their radiological appearance, the
lesions were dichotomized in “simple” versus abscessed
(at least one abscessed lesion) and in single versus mul-
tiple. Further imaging parameters were unilateral versus
bilateral involvement and presence of kidney scars at
diagnosis.
Informed consent for publication of the clinical data
in anonymous form was obtained from all patients at
the first nephrological control. Further specific informed
consent was obtained from the patient whose images
are depicted in Figures 1 and 2.
Statistical analysis
Descriptive analysis was performed as appropriate (mean
and standard deviation for parametric data and median
and range for non-parametric data). Student’s t-test, chi-
square test and ANOVA were used for comparisons
between groups. Significance was set at < 0.05.
Univariate odds ratios and multivariate regressions
were calculated in SPSS (version 17.0). Logistic regres-
sion was performed considering the type of lesion
(abscessed lesion) or the number of lesions (multiple
lesions) as outcomes, with respect to the main clinical
data (age, fever, costovertebral tenderness, lower urinary
tract symptoms, duration of symptoms and their combi-
nation), presence of renal scars and C-reactive protein
as a marker of inflammation. Continuous data were
dichotomized at the median.
Results
Baseline data
In the period June 2005-December 2009, 119 patients
with an imaging-confirmed diagnosis of acute non-com-
plicated APN were hospitalized in our setting. The inci-
dence was stable throughout the period: overall 2.2
cases/month (2.3 in 2005 and 2.6 in 2009). The referral
area of the university hospital includes approximately
100,000 inhabitants; thus, the incidence corresponds to
roughly 265 cases per year per million population (or
2.65 per 10,000 inhabitants, as the incidence of APN is
often reported). The prevalence of the different types of
upper UTI was assessed in a sample of 85 cases hospita-
lized in the Emergency department in 2008-2009 with
the diagnosis of “upper UTI”. In 6 cases the final diag-
nosis was of a different infection. In the other 79 cases,
there were 33 non-complicated APN (42%), 32 compli-
cated APN (with predisposing factors) (40%), and 14
upper UTI without radiological signs of parenchymal
involvement (18%).
In keeping with the diagnosis of non-complicated (or
uncomplicated) APN, all patients were females with
normal genitourinary tract, with a median age of 32
years and a wide age range (15-72 years). A history of
kidney stones was present in 19/119 patients (16%);
none had active stone disease according to the defini-
tion of “non-complicated” pyelonephritis. Forty-nine
patients had had at last one pregnancy (41%); 21
Figure 1 Large simple lesion: a) T1 weighted sequence showing a large pyelonephritis focus in the right kidney; b) same area in
diffusion: the large cuneiform lesion is clearly evident due to the intense edema.
Piccoli et al. BMC Nephrology 2011, 12:68
http://www.biomedcentral.com/1471-2369/12/68
Page 4 of 10(17.7%) were taking anti-progestagens; a history of fre-
quent urinary tract infections was reported by about
half of the cases (table 1).
Imaging at diagnosis
By definition, diagnosis was made by a second-line ima-
ging technique. MR was performed in 105 cases, CT
scan in 11, while renal scintigraphy was the second-line
test in 3 patients with contraindication to both CR and
MR (claustrophobia, multiple allergies). In these 3 cases,
the lesions were considered non-abscessed on the basis
of the negativity of ultrasound, sensitive to the presence
of abscessed lesions.
The severity of the lesion was not uniform; “simple”
non-abscessed lesions only were present in 72 patients
(60.5%) while at least one abscessed lesion was present
in 47 patients (39.5%) (table 1, Figure 1, 2). About 20%
of the patients (24 cases) had a single renal lesion.
L e s i o n sw e r em u l t i p l ei n9 5cases (79.8%) and bilateral
in 16 patients (13.5%).
In 18/119 patients (15.1%) one or more renal scars
were detected at the time of diagnosis. They were con-
sidered a sign of previous APN. However a previous
APN episode was reported in only 3 cases.
There was no difference in the clinical history between
patients with single or multiple kidney lesions. In the
univariate comparison of patients with non-abscessed
versus abscessed lesions, the only statistically significant
difference was the higher prevalence of previous stone
diseases in the patients with “simple” lesions (table 1).
Figure 2 (same patient as in figure 1)large abscessed lesion: a9 T1 weighted late contrast sequence showing a large abscessed focus
in the right kidney; b) same area at diffusion. The round shape is clearly evident in both sequences.
Table 1 Baseline data of the studied population (clinical history)
Patient features Single
lesions
Multiple lesions P Simple lesions Abscessed
Lesions
p All cases
N 24 95 - 72 47 - 119
Age 28
(15-72)
33
(15-68)
0.38* 30.5
(15-72)
34
(16-63)
0.80* 32
(15-72)
History of frequent UTI 14
(58.3%)
41
(43.6%)
0.29^ 38
(52.8%)
17
(36.2%)
0.11^ 55
(46.2%)
Previous scars (APN) 2
(8.3%)
16
(16.8%)
0.47^ 13
(18.1%)
5
(10.6%)
0.4^ 18
(15.1%)
History of stone disease (§) 5
(20.8%)
14
(14.7%)
0.68^ 16
(22.2%)
3
(6.4%)
0.04^ 19
(16%)
Previous pregnancy 9
(37.5%)
40
(42.1%)
0.69^ 31
(43.1%)
18
(38.3%)
0.29^ 49
(41.2%)
Birth control pills 5
(20.8%)
21
(22.1%)
1^ 15
(20.8%)
11
(23.4%)
0.92^ 26
(21.8%)
* Mann-Whitney U test
^ Pearson’s chi-square test
§ By definition, patients with active stone disease were excluded.
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According to the diagnostic criteria, all patients dis-
played at least one of the hallmarks of the classical pre-
sentation of APN (high fever, costovertebral pain and/or
tenderness, signs or history of recent UTI), plus at least
one sign of infection/inflammation (high CRP level,
increase in WBCs) (table 2). However, the three symp-
toms together (high fever, costovertebral pain and/or
tenderness, signs or history of recent UTI) were present
in only about one third of the cases (42 patients; 35.3%).
The full-blown picture (the “clinical tetrad” including
the main three symptoms mentioned above, plus posi-
tive urinary cultures) was present in only 13 cases (11%).
The median interval between the first symptoms and
referral to the ER was 3 days (3 or more days in 61%),
in keeping with a relatively late referral in our setting
where patients are routinely assessed by the family phy-
sician before hospital referral.
Urinary cultures were positive in 23.5% of the patients.
Antibiotic therapy in the last three days was reported at
admission by 50 patients (42%). None of the main clini-
cal features at presentation (lumbar pain, lower urinary
tract symptoms, fever) showed a significant difference
between patients with positive or negative urinary cul-
tures; however there was marginal significance for pre-
vious antibiotic therapy (p = 0.051). There was no
difference in the interval from onset of symptoms to
referral between patients with positive or negative urin-
ary cultures; however the range was wider in the latter
(1-30 days versus 1-7 days), suggesting that a long
interval between symptoms and referral may have con-
tributed to the low prevalence of positive urinary cul-
tures, at least in selected patients (table 2).
All the biochemical parameters were widely scat-
tered. None of the main clinical and laboratory data at
referral discriminated the presence of multiple lesions
or the presence of at least one abscessed lesion. The
only significant differences at presentation were a
higher prevalence of positive urinary cultures in multi-
ple and non-abscessed lesions and a higher incidence
of the full-blown tetrad in patients with abscessed
lesions (table 2).
Multivariate analysis
T a b l e s3a n d4r e p o r tt h er e s u l t so ft h em u l t i v a r i a t e
analysis of the outcomes of multiple lesions (versus sin-
gle) and abscessed lesions (versus non-abscessed
lesions). For the outcome multiple versus simple lesions,
statistical significance was reached for the combined
variable of positive urinary culture and/or positive
hemoculture (Odds Ratio of about 4) (table 3). Conver-
sely, no biochemical or clinical marker at presentation
showed a significant correlation with the presence of
abscessed lesions at diagnosis (table 4).
Discussion
The present study was performed in a setting in which
patients with a clinical suspicion of “non-complicated”
APN are routinely hospitalized and undergo an exten-
sive imaging work-up (ultrasound and either MR or CT
scans) [31-33].
Table 2 Main clinical and biochemical data at presentation
Single
lesions
Multiple
lesions
p Simple
lesions
Abscessed
lesions
p All cases
SCr (mg/dL) 1.03 ± 0.43 0.89 ± 0.28 0.07° 0.95 ± 0.37 0.89 ± 0.22 0.26° 0.92 ± 0.32
CRP (mg/dL) 10.3
(1.3-39)
12.5
(0.2-36)
0.41* 10.6 (0.3-39) 13.3
(0.2-31)
0.14* 12.1
(0.2-39)
WBC (n/mm3) 13042 ± 4128 12397 ± 4139 0.49° 12103 ± 4185 13194 ± 3990 0.16° 12528 ± 4127
Positive urinary cultures 12.5% 26.3% 0.25^ 19.4% 30% 0.28^ 23.5%
Positive hemocultures 0% 15.8% 0.004^ 16.7% 6.4% 0.014^ 12.6%
Fever 39
(36-40)
39
(36-41)
0.12* 39
(36-40)
39
(36-41)
0.17* 39
(36-41)
Flank pain - tenderness 87.5% 88.4% 1^ 84.7% 93.6% 0.24^ 88.2%
Lower urinary tract symptoms 62.5% 43.2% 0.14^ 41.7% 55.3% 0.20^ 47.1%
Antibiotic treatment in the last 3 days 54% 39% 0.31^ 43.1% 40.4% 0.33^ 42%
Time between symptoms and diagnosis 3 (1-14) 3 (1-30) 0.54* 3 (1-30) 3 (1-20) 0.36* 3 (1-30)
Tetrad (fever, pain, lower UTI, positive cultures) 8.3% 11.7% 0.92^ 5.6% 19.6% 0.039^ 11%
Eligible for a trial (tetrad and no recent antibiotic
therapy)
4.2% 9.5% 0.67^ 4.2% 14.9% 0.08^ 8.4%
UTI: Urinary tract infection
*Mann-Whitney U test
°Student’s t-test
^Pearson’s chi-square test
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dence of APN was reported as 20-35 new cases per year
per 10,000 inhabitants [34-37]. Thus the gross incidence
was about 10 times higher than in our study (about 2.5
new cases per year per 10,000 inhabitants). However it
is difficult to compare the incidence data in our study
with those in the literature, for two main reasons.
Firstly, the definition of APN rests on different bases.
Imaging data are not included in the diagnostic work-up
in the USA and Korea but are required for diagnosis in
our setting. Secondly, in the absence of an imaging
work-up, the incidence data in the USA and Korea
include both non-complicated and complicated
pyelonephritis while our study was limited to the former
category. In our setting the ratio between “complicated
or secondary” and “non-complicated or primary” APN is
approximately 3:1 in the Emergency Room (ER), a find-
ing that could at least partly explain the difference.
Unlike other settings, Italian ERs are usually the sec-
ond referral point after the family physician; both family
physicians and ERs are provided by the national health
care system and are free of charge. An efficient filter by
family physicians could be postulated on the basis of the
42% prevalence of antibiotic treatment in the last 3 days
and of a median time of 3 days between the onset of
symptoms and hospitalization.
Table 3 Multivariate logistic regression: risk of multiple lesions
N = 119 Number in
Group
Multiple
lesions
(N = 95)
% OR - UNI CI 95% - UNI OR - MULTI
1 CI MULTI
Age ≤ 32 years 62 47 75.8% 1
Age > 32 years 57 48 84.2% 1.702 0.679-4.267 1.699 0.620-4.653
Scars at diagnosis
NO
101 79 78.2% 1
Scars at diagnosis
YES
18 16 88.9% 2.228 0.476-10.434 1.81 0.349-9.383
CRP < 12 mg/dL 58 45 77.6% 1
CRP > = 12 mg/dL 58 47 81.0% 1.234 0.501-3.039 1.151 0.425-3.117
Negative urinary cultures or hemocultures 81 60 74.1% 1
Positive urinary cultures and/or
hemocultures
38 35 92.1% 4.083 1.136-14.679 4.204 1.139-15.515
Presence of the 3 main symptoms 77 65 84.4% 1
Absence of at least one of the 3 main
symptoms
42 30 71.4% 0.462 0.186-1.146 0.437 0.168-1.13
CRP (C-reactive protein); Age: dichotomized at the median. Three main symptoms: fever; lumbar pain-tenderness; symptoms of lower UTI
Table 4 Multivariate logistic regression: risk of abscessed lesions
N = 119 Number in
Group
Abscessed
lesions
(N = 47)
% OR - UNI CI 95% - UNI OR - MULTI
1 CI MULTI
Age ≤ 32 years 62 23 37.1% 1
Age > 32 years 57 24 42.1% 1.233 0.591-2.575 1.003 0.442-2.276
Scars at diagnosis
NO
101 42 41.6% 1
Scars at diagnosis
YES
18 5 27.8% 0.540 0.179-1.631 0.732 0.222-2.421
CRP < 12 mg/dL 58 17 29.3% 1
CRP > = 12 mg/dL 58 27 46.6% 2.101 0.977-4.516 2.095 0.921-4.767
Negative urinary cultures or hemocultures 81 32 39.5% 1
Positive urinary cultures and/or hemocultures 38 15 39.5% 0.999 0.454-2.197 1.010 0.437-2.335
Presence of the 3 main symptoms 77 26 33.8% 1
Absence of at least one of the 3 main
symptoms
42 21 50.0% 1.962 0.911-4.226 2.080 0.932-4.641
CRP (C-reactive protein); Age: dichotomized at the median. Three main symptoms: fever; lumbar pain-tenderness; symptoms of lower UTI
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aim of describing the clinical presentation of imaging-
confirmed APN. From the practical point of view we
wanted to identify clinical or biochemical markers of
severity of the kidney lesions (multifocal and abscessed
lesions) to test the alternatives to our imaging-guided
diagnostic and therapeutic approach.
The key feature of our study is the high prevalence of
severe lesions: multiple lesions were present in 79.8% of
the patients and abscessed lesions in 39.5%.
In spite of the severity of the lesions we found a high
prevalence of incomplete clinical presentations, lacking
the full-blown syndrome classically described as high
fever, signs or history of recent lower UTI, costoverteb-
ral flank pain or tenderness and positive urinary cultures
(table 2). The three symptoms were present at hospitali-
z a t i o ni na b o u to n et h i r do fc a s e sa n dl o w e ru r i n a r y
tract symptoms were present in about half of the
patients (47%). These clinical hallmarks are usually
included in the enrollment criteria for clinical trials for
APN, together with positive urinary cultures and no
recent antibiotic therapy [6]. According to these criteria,
only about 10% of our patients would have been eligible
for a recent clinical trial on APN (table 2).
The frequent negativity of the urinary cultures
deserves further comment. About half of the cases were
treated with antibiotics but the difference between cases
with positive and negative cultures was only marginally
significant (p = 0.051). The relatively long interval
between onset of symptoms and hospitalization and the
frequent lack of lower urinary tract symptoms suggest
alternative and adjunctive explanations.
Interestingly, a similar prevalence was found in a pre-
vious study, performed in a different setting (the largest
University Hospital of the Region) in 2004-2006, in
which the prevalence of positive urinary cultures was
even lower (20.7%), albeit with a higher recall of antibio-
tic therapy (95%) [32]. This observation may indicate a
“referral” bias (patients are usually referred to the emer-
gency room after a few days of empirical therapy), more
than a laboratory bias.
To further assess this point, we planned an analysis in
the Emergency room to test the hypothesis that, in
some cases, cultures may have been performed after the
first dose of intravenous antibiotics (as may occur over-
night or during the weekend, when urine sampling may
be erroneously postponed in a crowded ER). The analy-
s i si ss t i l lo n g o i n g ;h o w e v e re v e ni ft h es a m p l i n gm a y
have been biased in some cases, this finding draws
attention to the fact that urinary cultures can become
negative after a single antibiotic dose, even in the pre-
sence of renal abscesses or multiple lesions.
It is difficult to explain the higher prevalence of posi-
tive cultures in non-abscessed lesions. Our hypothesis is
that this may be due to the fact that the bacteria are
“sequestered” in abscessed lesions. However further ana-
lysis on larger cohorts is needed to confirm this appar-
ent paradox.
The difficulty in diagnosing APN is further underlined
by the fact that over 15% of the patients displayed renal
scars at the first imaging test, presumably as a result of
previous APN episodes; APN had been previously diag-
nosed in only a minority of them (3/18).
In this context and within these limits, the major find-
ing of our study is the lack of correlation between the
severity of the renal lesions and the clinical and bio-
chemical data at presentation (table 1, table 2, table 3
table 4). In fact oligosymptomatic presentation may
coexist with abscessed or multifocal lesions and none of
the tested parameters discriminated the severity of par-
enchymal involvement. This is of particular relevance
for abscessed lesions which require long-term antibiotic
therapy and are at high risk for the development of kid-
ney scars [15-17,23,25,32].
Like all clinical studies, ours has strengths and weak-
n e s s e s .T h em a i ns t r e n g t h sa r et h en o v e l t ya n dt h es y s -
tematic referral pattern with a diagnostic use of second-
line imaging techniques. To our knowledge, this is the
largest series of adults published in the last 10 years,
combining a clinical and imaging work-up of all cases of
suspected APN referred to the ER of a relatively large
hospital in a short time span.
The limitations are partly shared by single-center obser-
vational studies. In the absence of a control group and of
epidemiological data on the world-wide incidence of “non-
complicated” APN, our data are hardly comparable with
the literature. The suggestion that we may be dealing with
negative selection of the cases, possibly due to the exten-
sive filter of family physicians, needs further confirmation
on a larger scale and in different settings. A potential con-
founder is the high prevalence of negative urinary cultures,
possibly reflecting the policy of empirical antibiotic treat-
ment before hospital referral and the lack of lower urinary
symptoms but also perhaps related to late testing. This
issue needs further analysis, also in view of the lack of
recent epidemiological data on the prevalence of negative
urinary cultures in APN [15-17,33-38].
These limitations may become suggestions for further
studies on the prevalence and type of parenchymal
involvement and on the clinical presentation in settings
with different incidence and referral patterns.
Conclusions
The diagnosis of APN is still a challenge. At least in set-
tings such as ours in which patients are referred to the
Emergency Room after a few days of empirical treat-
ment, the prevalence of incomplete oligosymptomatic
presentations is high.
Piccoli et al. BMC Nephrology 2011, 12:68
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(39.5%), severe kidney involvement coexisted with
incomplete presentations. None of the clinical or bio-
chemical markers at presentation allowed discrimination
between small simple lesions and multifocal or
abscessed ones. Hence imaging techniques were needed
to assess the severity of kidney involvement and to plan
the antibiotic therapy. The relatively high prevalence of
kidney scars at presentation (15.1%), mostly with a silent
clinical history, draws attention to the difficulty in diag-
nosing and preventing long-term sequelae of APN.
Therefore, we believe that two recommendations for
clinical practice can be drawn from our experience.
First, the differential diagnosis of APN should be consid-
ered in all patients presenting at least one suggestive
clinical feature (fever, flank pain, lower UTI symptoms)
accompanied by high inflammatory markers. Second,
second-line imaging tests (MRI or CT scans) should be
systematically used to define the prevalence and type of
parenchymal lesions in order to tailor interventions to
the specific clinical contexts.
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